BILLING NEWS

Prenatal Cystic Fibrosis Screening Update for Feb. 2009

Effective for dates of service on or after February 1, 2009, providers performing molecular diagnostic testing to screen for the presence of a mutant cystic fibrosis gene may bill for a quantity greater than 25 for the combination of required laboratory tests (CPT-4 codes 83890 - 83914).

In addition, the following conditions apply:

  • When codes 83890 - 83914 are used to bill for the purpose of cystic fibrosis screening tests, ICD-9-CM code V26.31 (testing of female of genetic disease carrier status) or code V26.34 (testing of male for genetic disease carrier status) is required.
  • Codes 83890 - 83914 must be billed with modifier 8A (genetic cystic fibrosis) when a potential carrier is tested for cystic fibrosis.
  • Screening for cystic fibrosis carrier status is limited to once in the recipient's lifetime.
  • The maximum reimbursement for any combination of the above codes remains $180.

Published by XIFIN
INDUSTRY NEWS TAGS: California Medi-Cal


Share This Post:

Search Billing News

Billing News By TAG

Billing News By DATE